27Initiatives in the fiscal year ended September 2023Key theme of strategyActions to improve both the quality and quantity of two-way communication with patients and medical professionalsEvolution of information provision using Skin Disease Regional Leaders who specialize in providing information based on regional characteristics and Medical Area Specialists who specialize in providing information on specific diseasesDissemination of evidence-based product information and creation of new value based on data from clinical trials and other sourcesMain results• Engaged in activities to raise awareness about diseases (area DTC*1) tailored to regional characteristics with a focus on social media• Set up an official LINE account for patients with atopic dermatitis to support itch treatment• Launched “Rosacea Navi,” a comprehensive and informative rosacea treatment website for patients• Started operating a system to certify targeted Skin Disease Regional Leaders in order to make advanced proposals for personalized medicine and standard medical care• Visited dermatologists and home health care physicians and area-specific lectures to contribute to regional healthcare systems• Concluded an agreement Collaboration and Cooperation for the Promotion of Home Health Care with Osaka Prefecture• Disclosed the number of adverse effects after the launch of Rapifort Wipes, Mitchga Syringes, and Rozex Gel on a website for medical professionals, and built a system to respond immediately to treatment plans and when adverse effects occur Recognized by dermatologists as the “most highly rated company” in safety-related information on pharmaceutical company websites*2• In activities to create evidence, we improved the accuracy of research questions by collecting patient feedback using quick surveys and social media from the research planning stage, and adopted PRO*3 as evaluation items. Published 16 papers and made nine presentations for academic societiesNumber of dermatologists in Japan to whom Maruho provides information through medical representatives (MRs)Number of medical professionals registered as Maruho Web members**1 Direct to Consumer: indicates pharmaceutical advertising directly targeting general consumers *2 Source: 2023 Multimedia White Paper on Physicians Summer Edition (MCI DIGITAL) *3 Patient Reported Outcome: A method and indicator used in clinical trials where a patient reports on their health condition subjectivelyMaruho Report 20233. Strategy for Value Creation Progress of the Medium-Term PlanSales, Marketing, and MedicalBuilding and evolving systems for gathering and providing information on people’s skin troublesMaruho provides and communicates appropriate information about products and diseases in a variety of ways, depending on the characteristics of each region. The information obtained through communication with medical professionals and people with skin problems is used not only for product development, but also for the provision of tools and mechanisms that lead to optimal treatment for each patient. Additionally, we identify in-demand information and unmet needs, and based on evidence such as clinical trials, we identify medical issues and create new knowledge and value regarding the efficacy and safety of treatments and products.With one of the most complete systems in Japan, we always aim to contribute to medical care and improve the Quality of Life of patients by promoting proper use of our products and disseminating correct knowledge about diseases.*Knowledge service for reading, knowing, and learning about dermatologyApprox.10,000Approx.36,000
元のページ ../index.html#28